Andrew Harkin

6.3k total citations
122 papers, 4.9k citations indexed

About

Andrew Harkin is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Biological Psychiatry. According to data from OpenAlex, Andrew Harkin has authored 122 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cellular and Molecular Neuroscience, 45 papers in Behavioral Neuroscience and 43 papers in Biological Psychiatry. Recurrent topics in Andrew Harkin's work include Stress Responses and Cortisol (45 papers), Tryptophan and brain disorders (43 papers) and Neurotransmitter Receptor Influence on Behavior (32 papers). Andrew Harkin is often cited by papers focused on Stress Responses and Cortisol (45 papers), Tryptophan and brain disorders (43 papers) and Neurotransmitter Receptor Influence on Behavior (32 papers). Andrew Harkin collaborates with scholars based in Ireland, Germany and Canada. Andrew Harkin's co-authors include Thomas J. Connor, John Kelly, Sinead M. Gibney, Brian E. Leonard, Joan B. O’Sullivan, Karen M. Ryan, Ruth McNamara, Ian A. Paul, Éadaoin W. Griffin and Neasa Starr and has published in prestigious journals such as New England Journal of Medicine, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Andrew Harkin

119 papers receiving 4.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Andrew Harkin 1.9k 1.5k 1.3k 857 792 122 4.9k
Thomas J. Connor 1.7k 0.9× 1.5k 1.0× 908 0.7× 595 0.7× 1.1k 1.4× 74 4.4k
Thomas C. Baghai 1.5k 0.8× 1.6k 1.1× 1.7k 1.2× 1.3k 1.6× 579 0.7× 170 6.7k
Francesca Calabrese 1.3k 0.6× 1.4k 0.9× 1.4k 1.1× 770 0.9× 374 0.5× 95 4.0k
Raffaella Molteni 1.3k 0.7× 1.6k 1.1× 2.6k 1.9× 1.5k 1.7× 798 1.0× 100 7.7k
Gislaine Z. Réus 3.3k 1.7× 2.0k 1.3× 1.8k 1.4× 1.4k 1.7× 820 1.0× 167 7.3k
Borja García‐Bueno 1.8k 0.9× 1.2k 0.8× 641 0.5× 1.1k 1.2× 1.2k 1.6× 94 4.5k
B. E. Leonard 1.5k 0.8× 1.6k 1.1× 2.1k 1.6× 1.1k 1.3× 580 0.7× 192 5.4k
Cornelius Schüle 1.2k 0.6× 1.5k 1.0× 1.4k 1.0× 879 1.0× 298 0.4× 126 5.1k
Manuella P. Kaster 1.5k 0.8× 883 0.6× 873 0.7× 925 1.1× 508 0.6× 79 3.9k
Gabriel R. Fries 2.3k 1.2× 963 0.6× 1.1k 0.8× 1.2k 1.4× 471 0.6× 144 5.8k

Countries citing papers authored by Andrew Harkin

Since Specialization
Citations

This map shows the geographic impact of Andrew Harkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Harkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Harkin more than expected).

Fields of papers citing papers by Andrew Harkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Harkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Harkin. The network helps show where Andrew Harkin may publish in the future.

Co-authorship network of co-authors of Andrew Harkin

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Harkin. A scholar is included among the top collaborators of Andrew Harkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Harkin. Andrew Harkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Stojanović, Nikola M., et al.. (2024). Essential Oil Constituents as Anti-Inflammatory and Neuroprotective Agents: An Insight through Microglia Modulation. International Journal of Molecular Sciences. 25(10). 5168–5168. 29 indexed citations
3.
Ryan, Karen M., et al.. (2024). Gene expression of kynurenine pathway enzymes in depression and following electroconvulsive therapy. Acta Neuropsychiatrica. 37. e34–e34. 2 indexed citations
4.
Fernández‐Aranda, Fernando, Lucía Camacho‐Barcia, Andrew Harkin, et al.. (2023). Insulin and disorders of behavioural flexibility. Neuroscience & Biobehavioral Reviews. 150. 105169–105169. 6 indexed citations
5.
Ruiz‐Hernández, Eduardo, et al.. (2023). Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery. Pharmaceutics. 15(3). 746–746. 55 indexed citations
6.
Moran, Barry, et al.. (2023). Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin. PubMed. 7(2). NS20220054–NS20220054. 23 indexed citations
7.
Midttun, Øivind, et al.. (2021). Kynurenic Acid Protects Against Reactive Glial-associated Reductions in the Complexity of Primary Cortical Neurons. Journal of Neuroimmune Pharmacology. 16(3). 679–692. 5 indexed citations
8.
Ryan, Karen M., et al.. (2021). PBMC telomerase activity in depression and the response to electroconvulsive therapy. European Archives of Psychiatry and Clinical Neuroscience. 271(7). 1297–1307. 3 indexed citations
9.
O′Neill, Eoin, Éadaoin W. Griffin, Carol Murray, et al.. (2020). Acute neuroinflammation, sickness behavior and working memory responses to acute systemic LPS challenge following noradrenergic lesion in mice. Brain Behavior and Immunity. 94. 357–368. 24 indexed citations
11.
O′Neill, Eoin, et al.. (2019). L‐alpha‐aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson’s disease in male rats. Journal of Neuroscience Research. 97(7). 804–816. 12 indexed citations
12.
O′Neill, Eoin, et al.. (2019). Pharmacological targeting of β2‐adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's disease. British Journal of Pharmacology. 177(2). 282–297. 32 indexed citations
14.
Abautret-Daly, Áine, Elaine Dempsey, Adolfo Parra‐Blanco, Carlos Medina, & Andrew Harkin. (2017). Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatrica. 30(5). 275–296. 139 indexed citations
15.
Sherwin, Eoin, Valentina Gigliucci, & Andrew Harkin. (2016). Regional specific modulation of neuronal activation associated with nitric oxide synthase inhibitors in an animal model of antidepressant activity. Behavioural Brain Research. 316. 18–28. 12 indexed citations
16.
Ryan, Karen M., Éadaoin W. Griffin, Katie J. Ryan, et al.. (2016). Clenbuterol activates the central IL-1 system via the β2-adrenoceptor without provoking inflammatory response related behaviours in rats. Brain Behavior and Immunity. 56. 114–129. 7 indexed citations
18.
19.
Harkin, Andrew, et al.. (2015). Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders. Neuropharmacology. 112(Pt B). 307–323. 115 indexed citations
20.
Hughes, Martina M., Angela Carballedo, Declan M. McLoughlin, et al.. (2012). Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain Behavior and Immunity. 26(6). 979–987. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026